We next tested whether low ING4 expression correlated with NF-κB activation in breast tumors by staining the TMAs with an antibody against the p65/RelA subunit phosphorylated at the amino acid residue serine 276 (p-p65/RelA), an activated form of NF-κB [47], [48]. Here, NFKB1 is linked to breast neoplasm.